JOHN BELMONT to Bone Marrow Transplantation
This is a "connection" page, showing publications JOHN BELMONT has written about Bone Marrow Transplantation.
Connection Strength
0.232
-
Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J Exp Med. 1991 Oct 01; 174(4):837-45.
Score: 0.078
-
Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol. 1988 Dec; 8(12):5116-25.
Score: 0.064
-
Enrichment and functional characterization of Sca-1+WGA+, Lin-WGA+, Lin-Sca-1+, and Lin-Sca-1+WGA+ bone marrow cells from mice with an Ly-6a haplotype. Blood. 1993 Nov 01; 82(9):2673-83.
Score: 0.023
-
Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector. Hum Gene Ther. 1991; 2(4):307-15.
Score: 0.019
-
Effects of leukemia inhibitory factor (LIF) on gene transfer efficiency into murine hematolymphoid progenitors. Adv Exp Med Biol. 1991; 292:131-8.
Score: 0.019
-
Expression vectors for human adenosine deaminase gene therapy. Genome. 1989; 31(2):832-9.
Score: 0.016
-
Expression of human CD18 in murine granulocytes and improved efficiency for infection of deficient human lymphoblasts. Hum Gene Ther. 1993 Feb; 4(1):25-34.
Score: 0.005
-
Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells. Hum Gene Ther. 1991; 2(3):203-13.
Score: 0.005
-
Gene replacement therapy for inborn errors of purine metabolism. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1065-71.
Score: 0.003